Position in GILD
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$865,429
-$415,381 QoQ
Shares Held
6,850
-25.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,142
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EagleClaw Capital Managment, LLC holds $45,392,435 across 12 Drug Manufacturers - General names. GILD ranks #10 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
71,774 | $18,061,209 | |
| 2 | JNJ |
Johnson & Johnson
|
22,283 | $5,659,213 | |
| 3 | MRK |
Merck & Co., Inc.
|
30,088 | $3,866,308 | |
| 4 | NVS |
Novartis AG
|
23,712 | $3,716,144 | |
| 5 | PFE |
Pfizer Inc
|
153,401 | $3,693,896 | |
| 6 | NVO |
Novo Nordisk A S
|
63,650 | $3,051,381 | |
| 7 | LLY |
ELI LILLY & Co
|
1,772 | $2,125,390 | |
| 8 | SNY |
Sanofi
|
45,410 | $1,937,190 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $865,429 | 6,850 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,280,810 | 9,190 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,152,528 | 9,390 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $953,490 | 8,590 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $952,373 | 8,590 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,082,403 | 9,660 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $836,872 | 9,060 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $759,590 | 9,060 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $599,308 | 8,735 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $639,838 | 8,735 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $747,317 | 9,225 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $691,321 | 9,225 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $753,359 | 9,775 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $835,922 | 10,075 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $942,203 | 10,975 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $677,047 | 10,975 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $666,002 | 10,775 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $622,738 | 10,475 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,003,833 | 13,825 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,994,469 | 42,870 | Shares | Sole | 2021-12-02 | |
| 2021-06-30 | $2,916,496 | 42,354 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,666,763 | 41,262 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,278,723 | 39,113 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,729,302 | 43,192 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $3,310,112 | 43,022 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,298,560 | 44,122 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||